Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Exmceuticalsinc (EXM.CN)

Exmceuticalsinc (EXM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 15,034
  • Shares Outstanding, K 75,728
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,253 K
  • 60-Month Beta 0.27
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade EXM.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings $-0.03 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.125 +60.00%
on 02/04/21
0.270 -25.93%
on 02/10/21
+0.050 (+33.33%)
since 01/08/21
3-Month
0.110 +81.82%
on 12/04/20
0.270 -25.93%
on 02/10/21
+0.030 (+17.65%)
since 11/26/20
52-Week
0.050 +300.00%
on 03/27/20
0.550 -63.64%
on 05/22/20
-0.130 (-39.39%)
since 02/26/20

Most Recent Stories

More News
EXMceuticals Inc. becomes member of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).

VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc.  ( CSE: EXM ) ( FSE: A2PAW2 ) (OTCQB:EXM…, (the "Company" or "EXM"), an emerging bio-sciences company specializing...

EXM.CN : 0.200 (+17.65%)
EXMceuticals Inc. Announces Receipt of Landmark COVID-19 Research Grant and Acceleration of Portuguese Activities

VANCOUVER, British Columbia, Sept. 08, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc.  ( CSE: EXM ) ( FSE: A2PAW2 ), (the "Company" or "EXM"), an emerging bio-sciences company specializing in the...

EXM.CN : 0.200 (+17.65%)
EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight COVID-19 Pandemic

VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc.  ( CSE: EXM ) ( FSE: A2PAW2 ), (the "Company" or "EXM"), an emerging bio-science company specializing in the production...

EXM.CN : 0.200 (+17.65%)
EXMceuticals Inc. Announces Shares for Debt Settlement

VANCOUVER, British Columbia, Aug. 21, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. ( CSE: EXM ) ( FSE: A2PAW2 ) (the “ Company ”) announces that it has settled $1,378,241 of debt with...

EXM.CN : 0.200 (+17.65%)
EXMceuticals Inc. Strengthens Positioning as a Gateway to the European Market through Supply Agreement for THC Distillate

VANCOUVER, British Columbia, June 11, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc.  ( CSE: EXM ) ( FSE: A2PAW2 ) , (the "Company " or " EXM" ), is pleased to announce that it has...

EXM.CN : 0.200 (+17.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 0.240
2nd Resistance Point 0.220
1st Resistance Point 0.210
Last Price 0.200
1st Support Level 0.180
2nd Support Level 0.160
3rd Support Level 0.150

See More

52-Week High 0.550
Fibonacci 61.8% 0.359
Fibonacci 50% 0.300
Fibonacci 38.2% 0.241
Last Price 0.200
52-Week Low 0.050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar